133 related articles for article (PubMed ID: 2139602)
21. Erythropoietin dose requirement in a patient with HbH disease and renal failure.
Winearls CG; Hughes RT; Pippard MJ; Cotes PM
Nephrol Dial Transplant; 1992; 7(10):1052-4. PubMed ID: 1331884
[No Abstract] [Full Text] [Related]
22. Seizures in dialysis patients treated with recombinant erythropoietin.
Beccari M; Romagnoni M; Sorgato G
Nephrol Dial Transplant; 1995; 10(3):423-4. PubMed ID: 7792048
[No Abstract] [Full Text] [Related]
23. [Recombinant human erythropoietin in the therapy of anemia in hemodialyzed patients].
Kakuk G; Kárpáti I; Mátyus J
Orv Hetil; 1990 Oct; 131(43):2365-6, 2369-71. PubMed ID: 2234936
[TBL] [Abstract][Full Text] [Related]
24. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
[TBL] [Abstract][Full Text] [Related]
25. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
Acharya VN; Sinha DK; Almeida AF; Pathare AV
J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
[TBL] [Abstract][Full Text] [Related]
26. Adverse effects of therapy for the correction of anemia in hemodialysis patients.
Watson AJ
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):30-4. PubMed ID: 2648519
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
Eiselt J; Veselá E; Racek J
Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661
[TBL] [Abstract][Full Text] [Related]
28. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
29. [A case of the good effect of low doses of erythropoietin].
Shostka GD; Dobronravov VA; Vasil'ev AN
Urol Nefrol (Mosk); 1991; (5):74-5. PubMed ID: 1755131
[No Abstract] [Full Text] [Related]
30. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
31. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of renal anemia with recombinant human erythropoietin].
Burghard R; Gordjani N; Leititis JU
Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
[TBL] [Abstract][Full Text] [Related]
33. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
[TBL] [Abstract][Full Text] [Related]
34. [Two new drugs. Recombinant "human" erythropoietin (EPO: Erypo, Recormon)].
Verwiebe R
Internist (Berl); 1992 Apr; 33(4):279-81. PubMed ID: 1612854
[No Abstract] [Full Text] [Related]
35. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
[No Abstract] [Full Text] [Related]
36. The use of subcutaneous erythropoietin in CAPD patients.
Piraino B; Johnston JR
Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
Mohini R
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartůnková J; Válek A
Cas Lek Cesk; 1989 Sep; 128(40):1257-60. PubMed ID: 2582471
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
